HYPONATREMIA IN COVID-19 PATIENTS

HYPONATREMIA AND INFLAMMATION AND CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04493268

Enrollment

250

Registered

2020-07-30

Start date

2020-03-07

Completion date

2020-07-21

Last updated

2020-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Virus Infection, Covid19, Hyponatremia

Keywords

INFLAMMATION, COVID, CORONA

Brief summary

SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Months to 100 Years

Inclusion criteria

* PATIENTS WITH SARS-CoV-2 INFECTION CONFIRMED BY PCR OF NASOPHARYNGEAL SWABS.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
MORTALITY	30 DAYS	HYPONATREMIA AND MORTALITY

Secondary

Measure	Time frame	Description
ICU HOSPITALIZATION	30 DAYS	HYPONATREMIA AND ICU HOSPITALIZATION

Countries

Argentina

Outcome results